Toggle Nav
Close
  • Menu
  • Setting

17-ODYA

Catalog No.
B6373
LTB4 ω-hydroxylase inhibitor
Grouped product items
SizePriceStock Qty
5mg
$55.00
In stock
10mg
$99.00
In stock
100mg
$699.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

17-ODYA (CAS: 34450-18-5) is a selective inhibitor of cytochrome P450 fatty acid ω-hydroxylase, an enzyme responsible for ω-hydroxylation reactions involved in steroid, cholesterol, and lipid metabolism. By blocking ω-hydroxylation, 17-ODYA reduces formation of bioactive lipid mediators, such as epoxyeicosatrienoic acids (EETs) and 20-hydroxyeicosatetraenoic acid (20-HETE). In rat renal cortical microsomes, 17-ODYA inhibits arachidonic acid ω-hydroxylation (IC50 <100 nM), resulting in enhanced sodium excretion and urine output. It also modulates vascular contractility and endothelium-mediated vasorelaxation, making it useful in vascular physiology and inflammation research.

Product Citation

Chemical Properties

Physical AppearanceA crystalline solid
StorageStore at RT
M.Wt280.45
Cas No.34450-18-5
FormulaC18H32O2
Solubility≥89.8 mg/mL in DMSO; ≥9.84 mg/mL in EtOH
Chemical Nameoctadec-17-ynoic acid
SDFDownload SDF
Canonical SMILESOC(CCCCCCCCCCCCCCCC#C)=O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control